NBY - NovaBay Pharmaceuticals, Inc.
1.48
0.050 3.378%
Share volume: 261,107
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$1.43
0.05
0.04%
View ratios
| Fiscal Date | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-07-2024 | 05-15-2025 | 08-14-2025 | 11-07-2025 | |
| Assets | |||||
| Total Assets | 3.877 M | 9.872 M | 6.911 M | 3.487 M | |
| Current Assets | 2.279 M | 9.038 M | 6.115 M | 2.898 M | |
| Inventories | 473.000 K | 0.000 | 467.000 K | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 776.000 K | 8.467 M | 5.344 M | 2.309 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 61.000 K | 12.000 K | 11.000 K | 6.000 K | |
| Other Assets | 1.537 M | 822.000 K | 785.000 K | 583.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||
| Total Liabilities and shareholders’ equity | 3.877 M | 9.872 M | 6.911 M | 3.487 M | |
| Total liabilities | 2.805 M | 3.705 M | 2.666 M | 1.853 M | |
| Total current liabilities | 1.984 M | 3.067 M | 2.144 M | 1.448 M | |
| Accounts Payable | 396.000 K | 800.000 K | 604.000 K | 76.000 K | |
| Other liabilities | 0.000 | 638.000 K | 522.000 K | 405.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 638.000 K | 522.000 K | 405.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.066 M | 6.161 M | 4.239 M | -2.683 M | |
| Common stock | 183.311 M | 181.948 M | 181.948 M | 181.134 M | |
| Retained earnings | -182.245 M | -175.787 M | -177.709 M | -183.817 M |